News | July 05, 2023
CARE reaffirms A+ rating to IOL Chemicals and Pharmaceuticals
The 'A+' rating reflects IOL's robust business model, diversified product portfolio
The 'A+' rating reflects IOL's robust business model, diversified product portfolio
Abbas will closely partner with CBC's business teams to identify, assess, and pursue investment opportunities and strategic acquisitions
Integration of modern and traditional medicine to facilitate the illness to wellness journey
All children (100%) in the presymptomatic intravenous cohort of LT-002 maintained or achieved all assessed motor milestones, including independent walking
The card-to-cloud device was launched into the U.S. and many other markets and is designed to work without an embedded communications module.
COR803 is a novel small molecule 3CLpro inhibitor discovered and developed by Cortexyme based on its expertise in cysteine protease inhibition.
By 2025, the company plans to achieve carbon and water neutrality, zero-waste to landfill, anti-microbial resistance stewardship and green chemistry
He was earlier associated with leading industry players like Hindustan Unilever, TATA Communications, Dr. Lal Path Labs, Oncquest and Metropolis Healthcare
The group had witnessed healthy revenue growth as revenue stood at Rs 251.14 crore in FY21.
He holds nine US patents and has published in multiple peer-reviewed journals and conferences
Subscribe To Our Newsletter & Stay Updated
